Your institution may have access to this item. Find your institution then sign in to continue.
Title
Availability of diphtheria antitoxin through an investigational new drug protocol.
Abstract
Offers information from the Centers for Disease Control and Prevention (CDC) about diphtheria antitoxin (DAT). The essential nature of access to DAT to ensure effective treatment of diphtheria; Information about the expiration date for the previously available supply of the DAT licensed in the United States; The DAT product now available in the United States through an Investigational New Drug (IND) protocol through CDC.